Innocell Corp - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Innocell Corp Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Innocell Corp. The Company's principal actvity is developing immune cell treatment drugs and the storage of immune cells. The Company's offerings include immune cell therapy, which is an anti cancer therapy using immune cells from the patient's own body; life cell bank, which collects and freezes anti cancer immune cells before receiving therapy that can weaken the immune system; cord blood bank, which stores hematopoietic stem cells and stem cells that are separated from core blood at an ultra low temperature, and extreme drug resistance (EDR) assay service, which is a test for patient's resistance to anti cancer drugs. The Company is also involved in the distribution of information technology (IT) products.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report